Mark S Chambers Selected Research

Mark S Chambers Research Topics

Disease

29	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 02/2004
27	Neoplasms (Cancer) 11/2022 - 09/2004
17	Xerostomia 01/2022 - 09/2004
8	Mucositis 01/2020 - 03/2006
5	Stomatitis 01/2020 - 07/2007
4	Osteoradionecrosis 01/2021 - 02/2004
4	Squamous Cell Carcinoma of Head and Neck 12/2020 - 03/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016 - 03/2012
2	Osteonecrosis (Kienbock's Disease) 11/2021 - 05/2021
2	Trismus (Lockjaw) 04/2021 - 07/2009
2	Oropharyngeal Neoplasms 01/2021 - 12/2004
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2017
2	Deglutition Disorders (Dysphagia) 01/2017 - 08/2015
2	Aspiration Pneumonia 01/2017 - 08/2012
2	Mouth Neoplasms (Oral Cancer) 11/2013 - 05/2012
2	Dental Caries (Decay, Dental) 01/2007 - 10/2006
2	Infections 03/2006 - 02/2004
2	Cognitive Dysfunction 02/2006 - 03/2002
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Fatigue 01/2022
1	Tongue Neoplasms (Tongue Neoplasm) 09/2021
1	Osteoporosis 05/2021
1	Dysgeusia (Parageusia) 12/2020
1	COVID-19 07/2020
1	Gagging 01/2020
1	Inflammation (Inflammations) 01/2020
1	Optic Nerve Diseases (Optic Neuropathy) 01/2020
1	Pain (Aches) 01/2020
1	Bullous Pemphigoid (Pemphigoid) 01/2020
1	Corneal Perforation 01/2020
1	Osteomalacia 01/2019
1	Hypophosphatemia 01/2019
1	Memory Disorders (Memory Loss) 01/2018
1	Tetanus 01/2018
1	Oral Ulcer (Mouth Ulcer) 01/2017
1	Exanthema (Rash) 01/2017
1	Pathologic Constriction (Stenosis) 01/2017
1	Dermatitis 08/2015
1	Weight Loss (Weight Reduction) 08/2015
1	Sialadenitis 07/2015
1	Oral Manifestations 01/2014
1	Multiple Myeloma 01/2014

Drug/Important Bio-Agent (IBA)

3	gamma-Aminobutyric Acid (GABA)IBA 01/2018 - 03/2002
3	cevimeline (Evoxac)FDA Link 08/2012 - 07/2007
2	Protons (Proton)IBA 11/2022 - 08/2015
2	Pharmaceutical PreparationsIBA 05/2021 - 04/2007
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Everolimus FDA Link 01/2018 - 01/2017
2	BenzodiazepinesIBA 01/2018 - 03/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2007 - 03/2006
2	Sodium Fluoride (Ossin)FDA Link 01/2007 - 10/2006
2	Tin Fluorides (Floran)FDA LinkGeneric 01/2007 - 10/2006
2	FluoridesIBA 01/2007 - 10/2006
2	Amifostine (Ethyol)FDA LinkGeneric 03/2006 - 12/2004
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Angiogenesis InhibitorsIBA 11/2021
1	Bone Density Conservation AgentsIBA 05/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Apoptosis Regulatory ProteinsIBA 01/2021
1	LigandsIBA 01/2021
1	ZincIBA 12/2020
1	AerosolsIBA 07/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2020
1	CytokinesIBA 01/2020
1	dihydroxy-vitamin D3IBA 01/2019
1	Fibroblast Growth Factor-23IBA 01/2019
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	AminesIBA 01/2018
1	maleic acid (maleate)IBA 01/2018
1	ONO-8590580IBA 01/2018
1	Hormones (Hormone)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	exemestane (Aromasin)FDA Link 01/2017
1	SolutionsIBA 01/2017
1	SteroidsIBA 01/2017
1	IodineIBA 07/2015
1	tetraethylpyrazine (TEP)IBA 08/2012

Therapy/Procedure

38	Radiotherapy 11/2022 - 02/2004
14	Therapeutics 12/2020 - 09/2004
10	Drug Therapy (Chemotherapy) 04/2021 - 09/2004
5	Stents 11/2022 - 04/2006
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022 - 03/2005
3	Proton Therapy 12/2021 - 08/2015
3	Enteral Nutrition (Feeding, Tube) 04/2021 - 08/2015
2	Chemoradiotherapy 01/2022 - 12/2008
2	Immunotherapy 01/2021 - 01/2020
2	Mandibular Osteotomy 01/2019 - 01/2003
2	Conservative Treatment 07/2015 - 07/2009
1	Prostheses and Implants (Prosthesis) 07/2022
1	Hematopoietic Stem Cell Transplantation 01/2017
1	Drug Tapering 01/2017
1	Dental Care 06/2016
1	Bone-Anchored Prosthesis 01/2016
1	Aftercare (After-Treatment) 01/2016
1	Free Tissue Flaps 01/2016
1	Adjuvant Radiotherapy 08/2015
1	Treatment Delay 01/2014
1	Gastrostomy 08/2012